HAE
Haemonetics Corporation
106.80$
-1.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 46.4% | 45.0% | 45.0% | 46.7% | 44.7% | 42.6% | 45.0% | 40.3% | 44.0% | 43.5% | 42.8% | 40.2% | 42.6% | |
| 53.6% | 55.0% | 55.0% | 53.3% | 55.3% | 57.4% | 55.0% | 59.7% | 56.0% | 56.5% | 57.2% | 59.8% | 57.4% | |
| 4.0% | 3.9% | 7.1% | 4.3% | 4.1% | 4.5% | 4.8% | 5.1% | 4.4% | 4.2% | 4.2% | 4.8% | 4.4% | |
| 33.0% | 33.2% | 31.5% | 32.2% | 31.0% | 30.5% | 34.8% | 34.4% | 31.0% | 31.5% | 34.9% | 35.0% | 33.2% | |
| 42.5% | 41.3% | 46.3% | 41.5% | 40.4% | 40.4% | 39.5% | 42.9% | 35.5% | 35.9% | 42.4% | 42.8% | 39.2% | |
| 11.1% | 13.7% | 8.7% | 11.8% | 15.0% | 16.9% | 15.6% | 16.8% | 20.6% | 20.5% | 14.9% | 16.9% | 18.2% | |
| 0.8% | 0.6% | 1.9% | 2.1% | 2.0% | 2.6% | 0.2% | 1.3% | 2.2% | 2.4% | 1.6% | 2.9% | 2.3% | |
| 10.3% | 13.1% | 6.8% | 13.9% | 12.9% | 14.3% | 21.4% | 14.1% | 15.7% | 17.7% | -8.2% | 14.0% | 9.6% | |
| 2.5% | 3.8% | 0.9% | 2.5% | 3.1% | 3.6% | 3.9% | 3.5% | 3.8% | 4.5% | -2.4% | 4.3% | 2.5% | |
| 7.8% | 9.3% | 5.9% | 11.4% | 9.8% | 10.8% | 17.5% | 10.6% | 11.8% | 13.2% | -5.8% | 9.7% | 7.1% | |
| 20.7% | 24.5% | 19.9% | 23.8% | 25.8% | 27.3% | 29.9% | 29.2% | 26.5% | 28.2% | 1.2% | 22.0% | 19.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.